Zobrazeno 1 - 10
of 129
pro vyhledávání: '"Linda C. Harlan"'
Autor:
Theresa H.M. Keegan, Ann S. Hamilton, Ashley W. Smith, Charles F. Lynch, Helen M. Parsons, Linda C. Harlan, Ian Landry, Pinki K. Prasad, Xiao-Cheng Wu
List of specific conditions in the AYA HOPE comorbidity index
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c7827b1db491a93916aaf448ef95d0d
https://doi.org/10.1158/1055-9965.22437532.v1
https://doi.org/10.1158/1055-9965.22437532.v1
Autor:
Theresa H.M. Keegan, Ann S. Hamilton, Ashley W. Smith, Charles F. Lynch, Helen M. Parsons, Linda C. Harlan, Ian Landry, Pinki K. Prasad, Xiao-Cheng Wu
Background: Existing comorbidity indices were not developed for adolescent and young adults (AYA) 15 to 39 years of age. The aim of this study was to assess impact of comorbidities on health care service needs and health status among AYA cancer survi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2f4f19d43429019ceaab38d1d3fdd43c
https://doi.org/10.1158/1055-9965.c.6515926
https://doi.org/10.1158/1055-9965.c.6515926
Autor:
Joan L. Warren, Edward L. Trimble, Kathleen A. Cronin, Jennifer L. Stevens, Linda C. Harlan, Nadia Howlader
Publikováno v:
Cancer Epidemiology, Biomarkers & Prevention. 28:539-545
Background: Black women with ovarian cancer experience worse survival than white women. Receipt of guideline care improves survival, yet care may vary by race. We assessed rates of guideline care and role of guideline treatment on survival disparitie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ac00695d3d19622d1e30e31bc012e637
https://doi.org/10.1158/1055-9965.epi-18-0285
https://doi.org/10.1158/1055-9965.epi-18-0285
Autor:
Joan L. Warren, Edward L. Trimble, Kathleen A. Cronin, Linda C. Harlan, Jennifer P. Stevens, Melvin Grimes
Publikováno v:
Gynecologic Oncology. 145:486-492
Background We assessed trends in the receipt of guideline care and 2-year cause-specific survival for women diagnosed with ovarian cancer. Methods This retrospective cohort analysis used National Cancer Institute's Patterns of Care studies data for w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e54c2516b5cb88215b14b2f291161784
https://doi.org/10.1016/j.ygyno.2017.03.016
https://doi.org/10.1016/j.ygyno.2017.03.016
Publikováno v:
Liver Cancer. 6:216-226
Background: The adoption of sorafenib into oncology practice as a first-line systemic treatment for advanced hepatocellular carcinoma (HCC) is not well understood. We examined sorafenib use since Food and Drug Administration (FDA) approval in 2007 an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a7c6529932c03d946f5d329dd9769a3
https://doi.org/10.1159/000473862
https://doi.org/10.1159/000473862
Publikováno v:
Oncology Research and Treatment. 40:174-183
Introduction: The 5-year survival of metastatic melanoma is < 18%. Historically, treatment options were limited. In 2011, 2 new agents were approved. Methods: We re-abstracted the medical records of a random sample (n = 520) of metastatic melanoma pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::07b297274ab1029047fb367cfef0d017
https://doi.org/10.1159/000456014
https://doi.org/10.1159/000456014
Autor:
Lynne Penberthy, Dave Annett, Quyen Tran, Kathleen A. Cronin, Donna R. Rivera, Xiao-Cheng Wu, Dennis Deapen, Lindsey Enewold, Deborah M. Winn, Scarlett Lin Gomez, Melissa Marth, Linda C. Harlan, Stephen M. Schwartz, Michael J. Barrett, Rosemary D. Cress, Joan L. Warren, Sally L. Glaser, Christopher I. Li
Publikováno v:
J Natl Cancer Inst Monogr
Journal of the National Cancer Institute. Monographs, vol 2020, iss 55
Journal of the National Cancer Institute. Monographs, vol 2020, iss 55
Oral anticancer medications (OAMs) are increasingly utilized. We evaluated the representativeness and completeness of IQVIA, a large aggregator of pharmacy data, for breast cancer, colon cancer, chronic myeloid leukemia, and myeloma cases diagnosed i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9413edfdc4afe10b30981ae70f5eb7af
https://pubmed.ncbi.nlm.nih.gov/32412073
https://pubmed.ncbi.nlm.nih.gov/32412073
Autor:
Linda C. Harlan, Theresa H.M. Keegan, Ronald D. Barr, Bradley H Pollock, W. Archie Bleyer, Lynn A. G. Ries, Denise Riedel Lewis
Publikováno v:
Cancer. 122:1000-1008
Incidence rates and trends of cancers in adolescents and young adults (AYAs) ages 15 to 39 years were reexamined a decade after the US National Cancer Institute AYA Oncology Progress Review Group was established.Data from the Surveillance, Epidemiolo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a0ae8791d3dac596933f4615dc27221d
https://doi.org/10.1002/cncr.29867
https://doi.org/10.1002/cncr.29867
Autor:
Lisa Shelton-Herendeen, Debra L. Friedman, Michael P. Link, Theresa H.M. Keegan, Brad Zebrack, Zinnia Loya, Jana Eisenstein, Pinki Prasad, Xiao-Cheng Wu, Stephen M. Schwartz, Keith M. Bellizzi, Vivien W. Chen, Jennifer Zelaya, Helen Parsons, Tiffany Janes, Martha Shellenberger, Urduja Trinidad, Marjorie Stock, Ashley Wilder Smith, Ann S. Hamilton, Mark Cruz, Gretchen Keel, Laura Allen, Rosemary D. Cress, Charles F. Lynch, Gretchen Agha, Karen Albritton, Ann Bankowski, Lori A. Somers, Michele M. West, Ikuko Kato, Linda C. Harlan, Ian Landry, Arnold L. Potosky
Publikováno v:
Cancer Epidemiology, Biomarkers & Prevention. 24:1844-1849
Background: Existing comorbidity indices were not developed for adolescent and young adults (AYA) 15 to 39 years of age. The aim of this study was to assess impact of comorbidities on health care service needs and health status among AYA cancer survi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f72ed853651247fed8c3500718e4a055
https://doi.org/10.1158/1055-9965.epi-15-0401
https://doi.org/10.1158/1055-9965.epi-15-0401
Autor:
Ann S. Hamilton, Linda C. Harlan, Stephen M. Schwartz, Ikuko Kato, Rosemary D. Cress, Theresa H.M. Keegan, Charles F. Lynch, Xiao-Cheng Wu, Ashley Wilder Smith
Publikováno v:
Pediatr Blood Cancer
Historically, adolescents and young adults (AYA) diagnosed with cancer have been an understudied population, and their unique care experiences, needs, and outcomes were not well understood. Thus, 10 years ago, the National Cancer Institute supported
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ec672d37bb8faa3fd9ac40db3d49f71
https://europepmc.org/articles/PMC7239374/
https://europepmc.org/articles/PMC7239374/